We believe synchronized drug delivery is life-saving precision.
The AirlCU Max+ is a portable medical device for single patients use.It is intended to aerosolize physician-prescribed solutions for inhalation topatients on and off ventilation orother positive pressure breathingassistance.
The AirICU Story – in intensive care nebulization area
AirICU belongs to the feellife group, a healthcare company centered around treating the upper and lower respiratory tracts of the human body. With the vision of "The Third Way of Dosing",
Our History
2024
• Received HCA Asia's Hospital Partnership of the Year.
2023
• Received the "World's Best Home Nebulizer Solution"award from the European media.
• Received the Global Vaccine Equipment Expert of the Year Award from Global Health & Medicine.
• Received MedTech Top 20 Innovative Healthcare Companies in the U.S.
• Air Smart Extra Lung Function Tester receives FDA K number.
2022
• Combination of global mesh nebulization ecology and modern traditional Chinese medicine innovation.
2019
• Launch the first AI intelligent nebulizer with imesh core technology worldwide.
2024
• Received HCA Asia's Hospital Partnership of the Year.
2023
• Received the "World's Best Home Nebulizer Solution"award from the European media.
• Received the Global Vaccine Equipment Expert of the Year Award from Global Health & Medicine.
• Received MedTech Top 20 Innovative Healthcare Companies in the U.S.
• Air Smart Extra Lung Function Tester receives FDA K number.
2022
• Combination of global mesh nebulization ecology and modern traditional Chinese medicine innovation.
2019
• Launch the first AI intelligent nebulizer with imesh core technology worldwide.
Patent Achievements
Contact AirICU
AirICU
marketing@air-icu.com
202 N California Ave, City of Industry, CA 91744
